Gilead Sciences has significantly expanded its global presence and capabilities through strategic acquisitions and the establishment of subsidiaries in areas such as oncology, virology, and cell therapy. By integrating innovative technologies and enhancing its product portfolio, Gilead aims to address evolving healthcare challenges, deliver advanced solutions, strengthen its market reach, and improve patient care across various regions worldwide.
Notable Acquisitions of Gilead Sciences
- CymaBay Therapeutics (Feb 12, 2024): Liver disease therapies, focusing on PBC.
- Immunomedics (Sep 13, 2020): Antibody-drug conjugates for cancer treatment.
- Kite Pharma (Aug 28, 2017): CAR-T therapies for hematologic cancers.
- Pharmasset (Nov 21, 2011): Groundbreaking hepatitis C antiviral therapies.
- Triangle Pharmaceuticals (Jan 23, 2003): HIV and antiviral drug development.
List of Gilead Sciences Acquisitions
S. No. | Acquiree Name | Announced Date | Price |
1 | CymaBay Therapeutics | Feb 12, 2024 | $4.3B |
2 | XinThera | May 09, 2023 | – |
3 | MiroBio | Aug 04, 2022 | $405M |
4 | MYR GmbH | Dec 10, 2020 | $1.62B |
5 | Immunomedics | Sep 13, 2020 | $21B |
6 | Forty Seven | Mar 02, 2020 | $4.9B |
7 | Cell Design Labs | Dec 07, 2017 | $567M |
8 | Kite Pharma | Aug 28, 2017 | $11.9B |
9 | Nimbus Apollo | Apr 04, 2016 | – |
10 | Epitherapeutics | May 06, 2015 | $65M |
11 | Phenex Pharmaceuticals | Jan 06, 2015 | $470M |
12 | YM BioSciences | Feb 08, 2013 | $487.6M |
13 | Pharmasset | Nov 21, 2011 | $11B |
14 | Calistoga Pharmaceuticals | Feb 22, 2011 | $375M |
15 | Arresto BioSciences | Dec 20, 2010 | – |
16 | CGI Pharmaceuticals | Jun 25, 2010 | $120M |
17 | CV Therapeutics | Apr 17, 2009 | $1.4B |
18 | Nycomed | Sep 08, 2007 | $48.3M |
19 | Raylo Chemicals | Nov 03, 2006 | $133.4M |
20 | Corus Pharma | Oct 22, 2006 | $365M |
21 | Myogen | Oct 02, 2006 | $2.5B |
22 | Triangle Pharmaceuticals | Jan 23, 2003 | $525.2M |
23 | NeXstar Pharmaceuticals | Jul 29, 1999 | – |
List of Gilead Sciences Subsidiaries
Here’s the list of Gilead Sciences Subsidiaries.
S. No. | Company | Country |
1 | Gilead Sciences Argentina SRL | Argentina |
2 | Cytopia Pty Ltd | Australia |
3 | Gilead Sciences Pty Ltd | Australia |
4 | Gilead Sciences YM Australia Pty Ltd | Australia |
5 | YM BioSciences Australia Pty Ltd | Australia |
6 | Gilead Sciences GesmbH | Austria |
7 | Gilead Sciences Belgium BV | Belgium |
8 | Gilead Sciences Belgium BVBA | Belgium |
9 | Gilead Sciences Farmacautica do Brasil Ltda | Brazil |
10 | Gilead Alberta ULC | Canada |
11 | Gilead Sciences Canada Inc | Canada |
12 | Gilead YM ULC | Canada |
13 | Fosun Pharma Kite Biotechnology Co Ltd | China |
14 | Gilead Sciences (Shanghai) Consulting Co Ltd | China |
15 | Gilead Sciences Hangzhou Pharmaceutical Co Ltd | China |
16 | Gilead Sciences Shanghai Pharmaceutical Technology Co Ltd | China |
17 | Gilead Sciences Colombia SAS | Colombia |
18 | Gilead Sciences sro | Czech Republic |
19 | Gilead Sciences Denmark ApS | Denmark |
20 | EpiTherapeutics ApS | Denmark |
21 | Gilead Sciences Finland Oy | Finland |
22 | Gilead Sciences SAS | France |
23 | Gilead Sciences GmbH | Germany |
24 | Immunomedics GmbH | Germany |
25 | MYR GmbH | Germany |
26 | Gilead Sciences Hellas EPE | Greece |
27 | Gilead Sciences Hong Kong Limited | Hong Kong |
28 | Gilead Sciences India Private Limited | India |
29 | Gilead Apollo Unlimited Company | Ireland |
30 | Gilead Biopharmaceutics Ireland UC | Ireland |
31 | Gilead Sciences Ireland Unlimited Company | Ireland |
32 | Gilead Therapeutics A1 Unlimited Company | Ireland |
33 | Gilead Ireland Research UC | Ireland |
34 | Gilead Oncology Ireland UC | Ireland |
35 | Gilead Therapeutics A2 Unlimited Company | Ireland |
36 | Gilead Sciences Israel Limited | Israel |
37 | Gilead Sciences Srl | Italy |
38 | Gilead Sciences KK | Japan |
39 | Gilead Sciences Luxembourg Sarl | Luxembourg |
40 | Gilead Sciences Malaysia Sdn Bhd | Malaysia |
41 | Gilead Sciences Mexico S de RL de CV | Mexico |
42 | Gilead Sciences Netherlands BV | Netherlands |
43 | Kite Pharma EU BV | Netherlands |
44 | KP EU CV | Netherlands |
45 | Gilead Sciences (NZ) | New Zealand |
46 | Gilead Sciences Norway AS | Norway |
47 | Gilead Sciences Americas S de RL | Panama |
48 | Gilead Sciences Poland Sp z oo | Poland |
49 | Gilead Sciences Lda | Portugal |
50 | Gilead Sciences (GSR) SRL | Romania |
51 | Gilead Sciences Russia LLC | Russia |
52 | Gilead Sciences Arabia Limited Company | Saudi Arabia |
53 | Gilead Sciences Singapore Pte Ltd | Singapore |
54 | Gilead Sciences Slovakia sro | Slovakia |
55 | Gilead Sciences South Africa (Pty) Ltd | South Africa |
56 | Gilead Sciences Korea Limited | South Korea |
57 | Gilead Sciences SLU | Spain |
58 | Gilead Sciences SL | Spain |
59 | Gilead Sciences Sweden AB | Sweden |
60 | Gilead Sciences Switzerland Sarl | Switzerland |
61 | Gilead Sciences Ilac Ticaret Limited Sirketi | Turkey |
62 | Gilead Sciences Europe Limited | United Kingdom |
63 | Gilead Sciences International Limited | United Kingdom |
64 | Gilead Sciences Limited | United Kingdom |
65 | MiroBio Ltd | United Kingdom |
66 | Asegua Therapeutics LLC | United States |
67 | Forty Seven Inc | United States |
68 | Forty Seven Holdings LLC | United States |
69 | Gilead Alberta LLC | United States |
70 | Gilead Apollo LLC | United States |
71 | Gilead Biopharmaceutics US LLC | United States |
72 | Gilead Calistoga LLC | United States |
73 | Gilead Connecticut Inc | United States |
74 | Gilead Holdings LLC | United States |
75 | Gilead Pharmasset LLC | United States |
76 | Gilead Sciences LLC | United States |
77 | Gilead Sciences Holding LLC | United States |
78 | Immunomedics Inc | United States |
79 | IBC Pharmaceuticals Inc | United States |
80 | Kite Pharma Inc | United States |
81 | Kite Pharma LLC | United States |
82 | neoKite Inc | United States |
83 | Tmunity Therapeutics Inc | United States |
84 | XinThera Inc | United States |